Accelerating orphan drug development
- PMID: 21119719
- DOI: 10.1038/nrd3340
Accelerating orphan drug development
Abstract
Interest in developing drugs for rare diseases has increased substantially in recent years. This article from the US Food and Drug Administration highlights the role of regulators in catalysing further progress in this field.
Comment on
-
Rare diseases, orphan drugs and their regulation: questions and misconceptions.Nat Rev Drug Discov. 2010 Dec;9(12):921-9. doi: 10.1038/nrd3275. Epub 2010 Nov 9. Nat Rev Drug Discov. 2010. PMID: 21060315 Review.
References
-
- Nat Rev Drug Discov. 2010 Jul;9(7):519-22 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
